Trial description:
A Phase 3 Multicenter, Open-label, Randomized Study of Rucaparib versus Chemotherapy in Patients with Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Contact name:
Dr James Brenton
Trial start date:
Tuesday, April 11, 2017
Trial end date:
Wednesday, December 30, 2020
Trial tumour type:
Gynaecological
Show on Radiotherapy:
No
